Phase 2 study of preoperative chemotherapy with nab-paclitaxel and gemcitabine followed by chemoradiation for borderline resectable or node-positive pancreatic ductal adenocarcinoma.
Emerson Y ChenAdel KardoshNima NabavizadehBryan FosterSkye C MayoKevin G BillingsleyErin W GilbertChristian LanciaultAaron J GrossbergKenneth G BenschErin MaynardEric C AndersonBrett C SheppardCharles R ThomasCharles D LopezGina M Vaccaronull nullPublished in: Cancer medicine (2023)
Gemcitabine and nab-paclitaxel followed by long-course chemoradiation represents a feasible neoadjuvant treatment strategy for borderline resectable or node-positive pancreatic cancer.